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Abstract:  It has recently been shown that quantitative phase imaging 
methods can provide clinically relevant parameters for red blood cell 
analysis with unprecedented detail and sensitivity. Since the quantitative 
phase information is dependent on both the thickness and refractive index, a 
major limitation to clinical translation has been a simple and practical 
approach to measure both simultaneously. Here we demonstrate both 
theoretically and experimentally that, by combining quantitative phase with 
a single absorption measurement, it is possible to measure both quantities at 
the single cell level. We validate this approach by comparing our results to 
those acquired using a clinical blood analyzer. This approach to decouple 
the thickness and refractive index for red blood cells may be used with any 
quantitative phase imaging method that can operate in tandem with bright 
field microscopy at the Soret-band wavelength. 
© 2011 Optical Society of America 
OCIS codes:  (170.0180) Microscopy; (170.1470) Blood or tissue constituent monitoring; 
(170.1530) Cell analysis; (170.1610) Clinical applications; (300.1030) Absorption; (180.3170) 
Interference microscopy 
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1. Introduction 
Current clinical technologies for analyzing red blood cells have remained essentially 
unchanged since the invention of impedance counters and flow cytometers. Although these 
methods provide high throughput measurements, the information provided is generally limited 
to population level statistics for morphology and bulk measurement in the case of hemoglobin 
concentration [1,2]. Even though automated counters have been developed to provide 
statistical information on both hemoglobin concentration distributions and general 
morphological information [3,4], they lack the resolution required to aid in a differential 
diagnosis. These limitations mean that if an abnormality is detected by an automated counter, 
pathologists must rely on manual qualitative analysis of blood smears for information on 
single cells. Furthermore, automated counters are expensive, bulky and costly to maintain 
making them unsuitable as a point of care diagnostic tool. Since the measurement of 
hemoglobin is of fundamental importance to blood analysis, several techniques such as 
Raman Imaging [5], magnetophoresis and gravitation sedimentation [6], FRET based sensing 
[7] and scattering based measurements [8] among many others have been developed. 
However, these methods also require complicated sample preparation or measurement 
procedures. 
It has recently been demonstrated that quantitative phase imaging (QPI) is capable of 
providing detailed, quantitative, morphological analysis as well as several novel clinically 
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optical phase shift through a red blood cell is a function of both thickness and refractive index, 
the demonstrated morphological analysis has depended on a priori  knowledge of the 
hemoglobin concentration [10,21]. Other groups utilizing phase measurements have addressed 
this problem in various manners. One popular approach utilizes two different immersion 
media to decouple the thickness and refractive index [22–24]. This approach requires that 
cells be kept in place as the media is changed and thus requires coating of the cover slips and 
a profusion setup. Thus, such a technique may not be well suited for clinical measurements 
especially with the goal of developing a point of care diagnostic tool in mind. More recently, 
it has been demonstrated that by acquiring diffraction phase microscope (DPM) measurements 
at different wavelengths, hemoglobin concentration may be quantified at the single cell level 
[25]. This technique, dubbed Spectroscopic Phase Microscopy, is highly stable and utilizes a 
relatively simple experimental setup and is therefore well suited for adoption as a clinical 
method. However, DPM requires modifications to the illumination path of a microscope and 
is not easily integrated with other popular modalities such as fluorescence measurements. 
Here we provide the proof of principle of a novel combination of the quantitative phase 
information measured using a Spatial Light Interference Microscope (SLIM) [26,27], with a 
bright field absorption measurement acquired in the Soret band. We show both theoretically 
and experimentally, that this combination can be used to quantitatively determine both 
hemoglobin concentration and cell morphology at the single cell level. SLIM is a new QPI 
modality which utilizes broadband illumination (400-700 nm, center wavelength of 530 nm) 
in common path geometry. Due to this SLIM provides the ability to measure optical path 
length with unparalleled sensitivities of 0.28 nm spatially and 0.029 nm temporally [16]. 
Furthermore, SLIM is designed as an add-on module to a commercial microscope and can 
easily be integrated with other commonly used modalities. 
The method described here may be deployed as a standalone blood smear analyzer in a 
clinical setting without relying on external measurements of hemoglobin concentrations. The 
additional set of measured parameters may offer insight into the nature of morphological 
abnormalities used to identify various disorders and will likely automate the diagnosis of 
conditions that currently require manual smear analysis. Such a method may be implemented 
for a fraction of the cost of current analyzers, requires no reagents or complicated sample 
preparation and has the potential to easily be adapted to a compact and portable platform 
[10,17]. The technique presented here may be also utilized with any QPI instrument, provided 
that it meets the resolution and sensitivity requirements for single erythrocyte analysis. 
2. Theory 
The phase measured by SLIM is related to the refractive index and thickness of the sample as 
  0 (,) (,)(,) xy k nxytxy φ ∆= ∆    (1) 
where k0 = 2π/λ and λ is the mean wavelength, t is the thickness, and Δn = (βC + nw) – ns. 
Here β is the refractive increment of protein in mL/g, C is the concentration in g/mL, nw is 
refractive index of water and ns  is the refractive index of the surrounding media. The 
refractive increment is defined as the increase in refractive index per one percent increase in 
the concentration [28–31]. It was shown in the 1950s that the refractive increments of a wide 
range of proteins lie within the range of 0.17 and 0.20 [28–31]. Furthermore, this is also true 
for other cellular components such as lipids and carbohydrates to the point that we may 
assume that the bulk refractive index of a living cell is a good measure of the total dry mass of 
the cell [17–21]. Given the small variations in refractive increment Eq. (1) can be rewritten in 
terms of the concentration and refractive increment as 
  [ ] 0 (,) (,) (,) ws xy k Cxy n txy φβ ∆ =+∆    (2) 
where Δnws = nw-ns is the difference between the refractive index of water and the surrounding 
media. The absorption measurements may be described according to the Lambert-Beer law: 
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where A is absorbance, σ is the absorption cross section perpendicular to the optical axis and 
N is the density of absorbers. The relationship between absorption cross section, density and 
refractive index is σN = 2k0n”, where n” is the imaginary part of the refractive index which 
describes the absorption phenomenon. For liquid solutions the absorbance is typically 
expressed in terms of a molar extinction coefficient: 
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where ε is molar extinction coefficient in L∙mol
−1cm
−1 at the wavelength being used, M is the 
molar mass (g/mol) and C is the concentration (g/L). It can be seen that the only unknowns in 
Eq. (2) and Eq. (3) are the thickness, t and concentration C. Therefore we may simply solve 
for both: 
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Thus, for a single molecular species case, as in the case of the almost homogenous red 
blood cell, only one absorption and one phase measurement is necessary to determine both the 
thickness and the concentration. 
3. Materials and methods 
3.1. Sample preparation 
Blood is drawn from patients at a local hospital by venipuncture and stored in EDTA coated 
containers at room temperature. A complete blood count (CBC) analysis is then performed on 
each sample using a clinical impedance counter (Coulter LH50, Beckman Coulter). This 
counter is used daily for routine analysis at the hospital’s hematology laboratory. To comply 
with HIPAA and University of Illinois Internal review board regulations each sample is 
marked with a unique identifier and all personal patient information is removed prior to 
transferring the samples to the university laboratory. Prior to imaging, the whole blood is 
diluted with Coulter LH series diluent (Beckman-Coulter) to a concentration of 0.2% whole 
blood in solution. This is the same diluent that is used by the impedance counter and fixes the 
cells morphology to prevent errors caused by flow in the measurement apparatus of the 
impedance counter. We use this diluent so that any effects that it does have on the 
morphology are also present in our measurements, such that a comparison with the clinical 
analyzer is possible. For imaging, a sample chamber is created by punching a hole in double 
sided scotch tape and sticking one side of the tape onto a cover slip. The sample is then 
pipetted into the chamber created by the hole and it is sealed on the top using another cover 
slip [21]. The cells are allowed to settle for 5 minutes prior to measurement. This sealed 
chamber allows control over the sample volume, prevents drying and reduces cell translation. 
This method provides uniform samples, which are quick and easy to prepare and is well suited 
for bench-top, proof of principle studies. 
3.2. Imaging 
For measuring the quantitative phase map, SLIM is used, which has been described in detail 
previously [26,27]. The  capabilities of SLIM have already been demonstrated in several 
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As shown in Fig. 1, SLIM is designed as an add-on module to a commercial phase contrast 
microscope (Zeiss Axio Observer Z1). For conventional phase contrast microscopy, a phase 
ring in the back focal plane of the objective is used to impart a π/2 phase shift to the un-
scattered light, relative to the scattered light. For SLIM, the back focal plane of the phase 
contrast objective is projected onto a liquid crystal phase modulator which is used to impart 
additional phase shifts to the un-scattered light in increments of π/2. In total 4 intensity images 
are recorded corresponding to phase differences of 0, π/2, π and 3π/2. A quantitative phase 
map may then be uniquely determined from these 4 images as previously described [26,27]. 
To ensure that the phase measured is integrated over the entire thickness of the cell we used a 
low numerical aperture (NA) objective. Thus, for both the SLIM and absorption 
measurements a 10x/0.3 Ph1 objective was used. The exposure time for each of the intensity 
maps is 15 milliseconds and a total of 0.75 second is required to acquire the 4 maps. 
 
Fig. 1. Experimental setup. The SLIM system is built as an add-on module to a commercial 
phase contrast microscope. The back focal plane of the objective is projected onto a spatial 
light modulator which is calibrated to impart a phase shift to the un-scattered light (yellow 
lines) relative to the scattered light (shown in red). Four intensity images are recorded 
corresponding  to  4  phase  shifts  in  increments  of  π/2,  the  quantitative  phase  map  is 
reconstructed from these 4 intensity images as detailed in Ref. [26]. For the SLIM 
measurements the illumination type is set to phase contrast and the filter wheel is set to an open 
position such that the entire spectrum of the halogen lamp is passed. For the absorption 
measurements the illumination type is set to bright field and a 430 nm filter is used in the filter 
wheel. The inset for the filter wheel shows the normalized intensity of the white light spectrum, 
the spectrum of the 430 nm bandpass filter (right axis) and the extinction coefficients of 
oxygenated and deoxygenated hemoglobin (left axis) as a function of wavelength from Ref. 
[33]. 
For measuring the absorption map a bandpass filter centered at 430 nm (+/− 10 nm) is 
introduced into the light path after the condenser field diaphragm as shown in Fig. 1. In 
principle any bandpass filter could be used, provided the SNR is high enough. The choice of 
430 nm was made since it is strongly absorbed by both oxygenated and deoxygenated 
hemoglobin. . The phase contrast annulus in the condenser is also swung out of position so 
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measurement, both the NA of the condenser and the objective must be taken into account. As 
for the SLIM measurement the NA of the objective must be chosen such that the depth of field 
is greater than the thickness of the red blood cells. The optimal NA for the condenser was 
determined experimentally by varying NA between 0.55 and 0.1 and measuring the 
absorption. It was found for multiple objectives (data not shown) that the absorption continues 
to increase as the NA is decreased and peaks at a value close to the NA of the objective being 
used. After this point, aberrations become clearly observable in the image. For the 10x/0.3 
objective used here, the value for the condenser NA which gave the greatest contrast was 
determined to be 0.2. For the absorption measurements an exposure time of 250 milliseconds 
is used. For each patient a 1.55 x 1.01 mm area is scanned corresponding to a 4x4 mosaic. 
When taking into account the time required for moving the stage and switching from SLIM to 
brightfield it takes approximately 2 minutes to measure each patient. 
Although in principle any QPI technique could be coupled with an absorption 
measurement to yield results similar to those shown here, we used SLIM for two main 
reasons. First, the white light illumination used for SLIM allows for easy integration of a filter 
wheel into the setup to perform absorption measurements. Second, SLIM provides the lowest 
noise and highest sensitivities out of any QPI technique that we are aware of. 
3.2. Data analysis 
 
Fig. 2. Image analysis (a) Quantitative phase map acquired using SLIM, color bar is in radians. 
(b) Absorption map acquired at 430 nm, color bar is in 16-bit gray scale values. (a-b) Insets 
show an example of a single RBC from the maps. (c) Overlay of l line profiles drawn through 
the center of a single cell, the phase values are shown in red against the left axis and the 
corresponding intensity from the absorption maps are shown in black against the right axis. (d) 
Average absorption vs. phase for each of the 7 patients analyzed in this study, a strong linear 
relationship (dotted line) indicates the feasibility of this method. For the cell shown here the 
volume and hemoglobin concentration were calculated to be 86.18 fL and 0.3 g/mL 
respectively. 
To analyze the images, a semi-automatic image routine was developed in MATLAB. A user 
selects several cells in every image, avoiding cells that are turned on their side or appear 
otherwise damaged. Using this routine it takes approximately 5 minutes to analyze the data 
from one patient. Once a cell is picked the region occupied by the cell is identified by 
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cell. As can be seen in the inset to Fig. 2a the red blood cell appears to be less circular than 
expected, this is due to the square aperture of the spatial light modulator (SLM) which is not 
large enough to allow all the high frequency components when a small numerical aperture 
objective is used. This problem can be overcome by adjusting the magnification of the SLIM 
system, using a higher NA objective or using a larger aperture SLM. For each cell a horizontal 
and vertical line profile are then measured through the center, for both the absorption and 
phase map (Fig. 2c). This approach assumes that the cells are radially symmetric, which is a 
reasonable approximation for red blood cells, although for future clinical work a pixel by 
pixel comparison will be ideal. From the phase profiles the peak values are chosen and from 
the intensity profile the minima are chosen. As can be seen in Fig. 2c, the phase and 
absorption profiles are in good agreement except for in the dimple region of the blood cell. 
For this reason, to demonstrate the feasibility of this technique just the peak values were 
chosen for the analysis presented here. Of course, for clinical translation, this mismatch must 
be understood and addressed. Figure 2d shows that the phase and absorption measurements 
are in fact linearly related and proves the feasibility of this approach. 
The peak values from the horizontal and vertical profiles are averaged and plugged into 
Eq. (5) and Eq. (6) to calculate the un-calibrated concentration and thickness values. For this 
analysis it is assumed that the blood cells are oxygenated and we obtained the absorption 
spectrum for hemoglobin from Ref. [33]. The volume for each cell is calculated by 
multiplying the average thickness, calculated from the line profiles, by the projected area of 
the cell. For calibration, the measured mean cell volume (MCV) and mean cell hemoglobin 
concentration (MCHC) values are plotted against the values reported by the CBC and a best 
fit line is calculate to provide a calibration function. In principle this analysis could be 
completely automated as previously shown [10,21], but is not necessary for the proof of 
principle of this technology. 
4. Results 
 
Fig. 3. Comparison of measured mean values with clinically reported values. (a) Mean Cell 
Volume, red error bars correspond to the SD reported by the Clinic and black error bars 
correspond to SD measured by the QPI and absorption measurements (b) Mean Cell 
Hemoglobin Concentration, error bars correspond to the measured SD, no SD information on 
the hemoglobin concentration is available from the Clinic. The dashed black lines have a slope 
of one. 
For this study, samples from a total of 7 patients were measured and total of 651 cells were 
analyzed with an average of 93 cells per patient. The comparison between the calibrated mean 
values from our measurements and the CBC values is shown in Fig. 3. It can be seen that both 
the measured MCV and MCHC agree well, with R
2 values of 0.86 and 0.79, respectively. The 
discrepancies are likely due to two major reasons. First, the MCHC reported by the clinic is 
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measurement is then made on this solution to calculate the hemoglobin concentration. 
Therefore, this measurement doesn't take into account any variability in hemoglobin 
concentration between cells. Secondly, the number of cells measured in this study is relatively 
low compared to the large numbers measured by the clinical impedance counters. Since the 
comparison between our measurements and the clinic relies on calibration, the agreement will 
likely increase with an increase in throughput. 
For the volume measurement, Fig. 3a also shows the standard deviations measured by the 
clinic in red and those measured by our technique in black. The lack of perfect agreement in 
the distribution widths is most likely due to the higher sensitivity of our method and the 
difference in the sample sizes measured. Although the clinical counter we are comparing our 
measurement to, does provide a histogram of size distributions for each patient, it does not 
have the capability to do the same for hemoglobin concentration, Fig. 3b thus only shows the 
standard deviations in the hemoglobin concentration distributions measured by our technique. 
The fact that the clinical analyzer in a major community hospital does not have this capability 
illustrates the need for a simple approach to provide this measurement. 
5. Discussion and conclusions 
In this study we have shown both theoretically and experimentally that by  combining 
quantitative phase measurements with bright field absorption measurements it is possible to 
calculate both cell morphology and hemoglobin concentration at a single cell level. The 
method was validated by comparing the values measured with those reported by a state of the 
art automated clinical blood analyzer. Although in this study a calibration was necessary, in 
the future a more detailed understanding of the formation of the bright field image may render 
this step unnecessary. In particular, the measured intensity includes contributions from 
scattered light and is not a pure absorption map as described by Beer's law. Furthermore 
Lambert-Beer's law must be rewritten for the case of convergent illumination as is provided 
by a typical microscope. The fact that the phase and absorption are linearly related, without 
taking these effects into account, indicates that the contribution from them is constant for red 
blood cells. 
Although we used SLIM to measure phase, in principle this technology could be utilized 
in combination with any QPI method. However, SLIM is well suited for this method since it 
does not require any modifications to a commercial microscope and the filter wheel required 
for the absorption measurements may easily be integrated with the white light illumination. 
The fact that SLIM requires 4 intensity measurements is only a practical issue as the advent of 
fast spatial light modulators, cameras and scanning software means that the speed of the 
measurement may easily be increased. Furthermore, the high SNR provided by SLIM ensures 
that data analysis technology can easily be automated to increase throughput. Since SLIM can 
simply be added as a modality to an existing microscope, minimal re-training will be 
necessary to use the equipment especially given that the parameters provided by this analysis 
are already familiar to pathologists and technicians. 
In conclusion, the technology presented here offers a powerful new blood screening tool 
that may aid pathologists in making differential diagnosis and risk stratification. This 
technology combined with the morphological analysis described previously [10,21] provides 
the ability to analyze red blood cells with unprecedented details and may enable new 
diagnostic capabilities when monitoring and treating red blood cell disorders. Furthermore, 
the ability to easily measure single cell hemoglobin concentrations may open new avenues for 
monitoring blood cell disorders and the effects of treatment. 
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